Ocular immune-related adverse events with immune checkpoint inhibitors: A retrospective cohort study.
BackgroundImmune checkpoint inhibitors (ICIs) are widely used to treat a variety of malignancies. Ocular immune-related adverse events (irAEs) have been increasingly recognized as rare side effects of these medications.MethodsWe performed a retrospective study of ocular irAEs at our institution between 2017 and 2025. O...